Market Vectors Pharmaceutical ETF (PPH)

Add to Watchlists
Create an Alert
74.22 +0.28  +0.38% NYSE Arca Jul 29, 17:00 Delayed 2m USD
View Full Chart
PPH Price Chart

PPH Description

Market Vectors Pharmaceutical ETF is a long only equity fund managed by Market Vectors that tracks the MV US Listed Pharmaceutical 25 NR USD index and has 413.36M USD assets under management. It has an forecasted dividend yield of 2.14%, a forecasted PE ratio of 22.84, and a forecasted price to book value of 3.501. The fund has a net expense ratio of 0.35%, turns over its positions 14.00% per year, and is traded on the New York Stock Exchange Arca.

PPH Key Info

Expense Ratio (2-1-15) 0.35%
Assets Under Management (7-28-15) 413.36M
30-Day Average Volume (7-28-15) 56559.43
Net Asset Value (7-28-15) 73.97
Discount or Premium to NAV (7-28-15) -0.04%
Turnover Ratio (9-30-14) 14.00%

PPH Asset Allocation

Type % Net % Long % Short
Cash -0.52% 0.00% 0.52%
Stock 100.5% 100.5% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of July 27, 2015

PPH Region Exposure

Americas 57.77%
North America 57.77%
Latin America 0.00%
Greater Europe 42.23%
United Kingdom 13.83%
Europe Developed 23.12%
Europe Emerging 0.00%
Africa/Middle East 5.28%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of July 23, 2015
Region breakdown data is calculated by using the long position holdings of the portfolio.

PPH Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of July 23, 2015

PPH Stock Market Capitalization

Giant 77.87%
Large 18.58%
Medium 4.07%
Small 0.00%
Micro 0.00%
As of July 23, 2015
View More Holdings

PPH Top 10 Holdings

Symbol Name % Weight Price % Chg
NVS Novartis AG ADR 7.68% 103.68 +0.87%
JNJ Johnson & Johnson 6.64% 99.73 +0.72%
PFE Pfizer Inc 5.47% 35.76 +1.17%
AGN Allergan PLC 5.39% 337.49 -0.59%
TEVA Teva Pharmaceutical Industries Ltd ADR 5.31% 70.83 -0.81%
SNY Sanofi ADR 5.24% 53.64 -0.32%
ABBV AbbVie Inc 5.05% 70.76 -0.66%
VRX Valeant Pharmaceuticals International Inc 5.02% 329.79 -1.23%
NVO Novo Nordisk A/S ADR 4.94% 59.36 +1.64%
GSK GlaxoSmithKline PLC ADR 4.81% 42.63 +2.21%
As of July 27, 2015
Advertisement

PPH Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Prospectus Objective Specialty - Health
Fund Owner Firm Name Market Vectors
Benchmark Index
MV US Listed Pharmaceutical 25 NR USD 100.0%

PPH Manager Info

Name Tenure
George Cao 3.28 yrs
Hao-Hung (Peter) Liao 3.28 yrs

PPH Risk Info

Beta 0.7998
Max Drawdown (All) 9.27%
Historical Sharpe (10y) --
Historical Sortino (All) 3.799
30-Day Rolling Volatility 15.12%
Daily Value at Risk (VaR) 1% (All) 1.90%
Monthly Value at Risk (VaR) 1% (All) 5.48%

PPH Fundamentals

Dividend Yield TTM (7-29-15) 1.64%
Weighted Average PE Ratio 23.10
Weighted Average Price to Sales Ratio 2.123
Weighted Average Price to Book Ratio 4.100
Weighted Median ROE 22.45%
Weighted Median ROA 8.93%
Forecasted Dividend Yield 2.14%
Forecasted PE Ratio 22.84
Forecasted Price to Sales Ratio 1.985
Forecasted Price to Book Ratio 3.501
Number of Holdings 27
As of July 27, 2015

PPH Growth Estimates

Forecasted 5 Yr Earnings Growth 7.85%
Forecasted Book Value Growth 5.85%
Forecasted Cash Flow Growth 3.59%
Forecasted Earnings Growth -1.67%
Forecasted Revenue Growth 7.87%
As of July 27, 2015

PPH Performance

  Returns Total Returns
1M 2.51% 2.91%
3M 3.57% 3.97%
6M 12.54% 13.79%
1Y 20.80% 22.99%
3Y 85.83% 102.2%
5Y -- --
As of July 28, 2015

PPH Net Flows

1M 13.93M
3M 35.74M
6M 20.39M
YTD 20.39M
1Y -20.63M
3Y 31.79M
5Y --
As of June 30, 2015

PPH Attributes

Key Dates
Inception Date 12/20/2011
Last Annual Report Date 9/30/2014
Last Prospectus Date 2/1/2015
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.